marijuana stocks

Form 8-K for INDIE GROWERS ASSOCIATION


2-Apr-2015

Changes in Registrant’s Certifying Accountant

Item 4.01 Changes in Registrant’s Certifying AccountantOn January 20, 2015, Sadler Gibb & Associates, LLC (“Sadler Gibb”) resigned as the Company’s independent registered public accounting firm.

Sadler Gibb has not issued any audit reports on the Company’s financial statements.

During the Company’s two most recent fiscal years and any subsequent interim period preceding Sadler Gibb’s resignation, there were no reportable events or disagreements with Sadler Gibb on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement(s), if not resolved to the satisfaction of Sadler Gibb, would have caused the Company to make reference to the subject matter of the disagreement(s) in connection with this report.

The Company has provided a copy of this disclosure to Sadler Gibb, and requested that Sadler Gibb furnish the Company with a letter, within the time periods prescribed by Item 304(a)(3) of Regulation S-K of Securities and Exchange Act of 1934, addressed to the Securities and Exchange Commission stating whether Sadler Gibb agrees with the statements made by the Company and, if not, stating the respects in which Sadler Gibb does not agree.

A copy of Sadler Gibb’s response to this Report on Form 8-K is attached hereto as Exhibit 16.1 to this current report on Form 8K.

 

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

HEXO Corp. (HEXO) and Entourage Health Sign Long-Term Supply Agreement

HEXO and Entourage Health Sign Long-Term Supply Agreement HEXO Corp. (TSX: HEXO;…

Green Thumb Industries Inc. (GTBIF) Announces US $217 Million Senior Debt Financing

Green Thumb Industries Announces US $217 Million Senior Debt Financing Green Thumb…

Cara Therapeutics, Inc. (CARA) Prioritizes Late-Stage Notalgia Paresthetica Program

Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into…

SOL Global (SOL) (SOLCF) Reports Second Quarter Results for the Three and Six-Month Period Ending September 30, 2019

TORONTO–(BUSINESS WIRE)– Invested Amount in Key Assets Including Heavenly Rx And Florida…